Author [reference] | Intervention | Population | Allocation | Cointerventions | Exclusion post- | Blinding of | Definition of |
---|---|---|---|---|---|---|---|
randomization | outcome accessor | VAP | |||||
Young et al [22] | Nasogastric | Head injury | `Was randomly | All patients received | 7 Exclusions: | Neurosurgen | Infiltrate and |
enteral nutrition | patients | assigned to' | prokinetic | 5-early death, 2 | evaluating | leukocytosis | |
vs total | -withdrew | outcomes was | premature cells, | ||||
parenteral | blinded | fever, positive | |||||
nutrition | sputum culture | ||||||
Moore et al [23] | Enteral nutrition | Trauma patients | `Randomized by | Broad spectrum | No exclusions: | Outcome | New infiltrate and |
via needle | requiring | computer | antibiotics to both | 4-early death, | assessment not | fever, leukocytosis | |
catheter | emergency | assignment' | groups | 3-reoperation, | blinded | and purulent | |
jejunostomy vs | celiotomy | 3-chronic illness, | sputum | ||||
total parenteral | 2-ATI> 40, | ||||||
nutrition | 2-head injury, | ||||||
1-mechanical | |||||||
failure, | |||||||
1-transfer | |||||||
Kudsk et al [24] | Enteral nutrition | Patients with blunt | `Computer | NR | 2 Exclusions: | Secondary | New infiltrate and |
via needle | and penetrating | generated | death within 4 | confirmation of | leukocytosis, | ||
jejunostomy vs | abdominal trauma | randomization | days | outcome by | positive sputum or | ||
total parenteral | table' | blinded surgeon | BAL, or purulent | ||||
nutrition | sputum | ||||||
Borzotta et al [25] | Enteral nutrition | Patients with | `Computer | Jejunostomy group | NR | Outcome | Infiltrate and |
via needle | severe closed head | generated random | had gastrostomy | assessment not | fever, leukocytosis, | ||
catheter | injury | number | tube drainage | blinded | leukorrhea and | ||
jejunostomy vs | assignment' | bacteria on Gram | |||||
nutrition | |||||||
Eyer et al [26] | Early (<24 h) | Patients with blunt | `Randomization by | All patients received | 14 Exclusions: | Outcome | New infiltrate and |
nasoduodenal | abdominal trauma | card drawn from | either sucralfate or | 3-regular diet, | assessment not | significant growth | |
tube feeding vs | sealed envelope' | antacids but group not | 3-steroids, | blinded | on sputum | ||
late (>72 h) | specified | 2-no NGT, | culture with <10 | ||||
nasoduodenal | 6-miscellaneous | epithelial cells, | |||||
tube feeding | >25 wbc/hpf OR | ||||||
secretions, fever | |||||||
and leukocytosis | |||||||
Montecalvo et al [27] | Gastric vs jejunal | Medical and | `Randomly | 25 Patients received | 5 Patients crossed | Cultures | New and |
tube feeding | surgical ICU | assigned | sucralfate; 1 H2RA; | over from jejunal to | reviewed blinded | persistent | |
patients | according to | 2 H2RA and antacids; | gastric group and | to group | infiltrate and | ||
computer | 8 sucralfate and | 2 patients crossed | assignment | three of: purulent | |||
generated random | either H2RA or | over from gastric | sputum with | ||||
number code' | antacids; 1 no stress | to jejunal group; | numerous | ||||
ulcer prophylaxis, but | these 7 patients | bacteria, purulent | |||||
group not specified | were included until | sputum with | |||||
the day they | nosocomial | ||||||
crossed over | pathogen, T>386, | ||||||
or wbc >10 | |||||||
Bonten et al [28] | Intermittent | Mixed ICU | `Randomization | Intermittent: 13- | None | Outcome | New and |
enteral feeding | patients and | was performed | antacids and 17- | assessment not | persistent | ||
(18 h) vs | cardiac surgery | with sealed | sucralfate; | blinded | infiltrate and 3 of: | ||
continuous | patients needing | envelopes' | continuous: 7 - | T>38 or T<355 | |||
enteral feeding | ventilation > 3 | antacids and 23 - | OR wbc > 10 | ||||
(24 h) | days | sucralfate | and/or left shift | ||||
or wbc < 3 OR 10 | |||||||
wbc/hpf on ET | |||||||
Gram strain OR | |||||||
positive ET | |||||||
aspirate and one | |||||||
of these: BAL | |||||||
(positive if > 104 | |||||||
CFU/ml) OR | |||||||
PSB (positive if | |||||||
>103 CFU/ml) | |||||||
OR positive | |||||||
blood culture OR | |||||||
positive pleural | |||||||
culture | |||||||
Gottsschlich et al [29] | Modular tube | Burn patients | `Random number | NR | NR | Physicians, | Infiltrate and |
feeding vs two | (>10% BSA) | table stratified for | nurses, | positive sputum | |||
standard enteral | age, center and | technicians, | culture and | ||||
feeding | burn size' | clinical and | systemic | ||||
(Osmolite vs | research | antibotics | |||||
Traumacal) | personnel were | ||||||
blinded | |||||||
Moore et al [30] | Early enteral | Trauma patients | `Randomized by a | NR | 16 exclusions: | Outcome | New and |
immune- | computer- | 9-inappropriate | assessment not | progressive | |||
enhancing | generated | randomizations, | blinded | infiltrate, fever, | |||
feeding vs | schedule' | 7-drop -outs | leukocytosis, | ||||
standard enteral | 1-early death | positive sputum | |||||
feeding | Gram stain with | ||||||
(Vivonex) | many polys | ||||||
Kudsk et al [31] | Early immune- | Trauma patients | `Computer- | Short-term broad | NR | All caregivers | New or changing |
enhancing | requiring | generated | spectrum antibiotics | blinded except | infiltrate and | ||
feeding via | emergency | randomization | to both groups | nutritionist | fever, | ||
jejunostomy vs | celiotomy | table' | leukocytosis, | ||||
standard enteral | purulent sputum | ||||||
feeding | underwent BAL | ||||||
(Promote) | (positive if > 103 | ||||||
CFU/hpf) |